Navigation Links
Lilly Reports Second-Quarter 2013 Results
Date:7/24/2013

INDIANAPOLIS, July 24, 2013 /PRNewswire/ --

  • Worldwide revenue increased 6 percent as growth in key products offset lower Zyprexa revenue following patent expirations in most major markets.
  • Cymbalta sales increased 22 percent while Cialis increased 13 percent.
  • Higher revenue and ongoing cost containment drove strong earnings growth.
  • Second quarter earnings per share grew to $1.11 (reported), or $1.16 (non-GAAP).
  • 2013 earnings per share guidance range raised to $4.28 - $4.38 (reported), or $4.05 - $4.15 (non-GAAP)
  • Eli Lilly and Company (NYSE: LLY) today announced financial results for the second quarter of 2013.

     $ in millions, except per share data

    Second Quarter

    %20132012

    GrowthTotal Revenue – Reported

    $5,929.7$5,600.7

    6%Net Income – Reported

    1,206.2923.6

    31%EPS – Reported

     

    1.110.83

    34%Net Income – non-GAAP

    1,254.9923.6

    36%EPS – non-GAAP

    1.160.83

    40% 

    Certain financial information for 2013 and 2012 are presented on both a reported and a non-GAAP basis. Some numbers in this press release may not add due to rounding. Reported results were prepared in accordance with generally accepted accounting principles (GAAP) and include all revenue and expenses recognized during the period. Non-GAAP measures exclude the items described in the reconciliation tables later in the release. The non-GAAP measures are presented in order to provide additional insights into the underlying trends in the company's business. The company's 2013 financial guidance is also being provided on both a reported and a non-GAAP basis.

    "In the second quarter, Lilly delivered solid financial results, highlighted by good revenue growth
    '/>"/>

    SOURCE Eli Lilly and Company
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

    Related medicine technology :

    1. After Reviewing Brief Product Profiles, Surveyed Physicians Believe that Likely Candidates for Late-Phase Chronic Kidney Disease Products from AbbVie, Mitsubishi Tanabe, Eli Lilly, Concert, Fibrogen and Pfizer are Typically Stage 3b and 4 Patients
    2. Lilly Disappointed in Draft Medicare Coverage Decision for Beta-Amyloid Imaging Agents
    3. The Zacks Analyst Blog Highlights: Walgreens, Express Scripts Holding, Haemonetics, ResMed and Eli Lilly
    4. Lilly Issues Alert for Illegal Scams Involving Fraudulent Checks and Online Job Requests
    5. Lilly Declares Third-Quarter 2013 Dividend
    6. Lilly Voluntarily Terminates Phase II Study for LY2886721, a Beta Secretase Inhibitor, Being Investigated as a Treatment for Alzheimers Disease
    7. Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company Statement on the ADA Request for Independent Review of Incretin-Based Therapies
    8. Lilly Statement on Indiana Biosciences Research Institute
    9. Lilly Announces Enzastaurin Phase III Study Did Not Meet Primary Endpoint in Diffuse Large B-Cell Lymphoma
    10. Lilly Announces CEO Dr. John Lechleiter to Undergo Scheduled Surgery
    11. Lilly Declares Second-Quarter 2013 Dividend
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/3/2015)... Sept. 3, 2015  Cipla, a global pharmaceutical company ... needs of all patients, today announced that its UK ... acquire two US-based companies, InvaGen Pharmaceuticals Inc., and Exelan ... conditions, is valued at $550 million and will be ... transactions is over $200 million for the year ended ...
    (Date:9/3/2015)... Sept. 3, 2015 Report ... to that Market, its R&D and Sales Potentials ... future of cancer-treating medicines? Visiongain,s new report gives you revenue ... There you discover financial data, R&D trends, opportunities, interviews and ... our analysis you see forecasted sales to 2025 at overall ...
    (Date:9/3/2015)... 3, 2015 About self-monitoring blood glucose ... home-based electronic device. It consists of a glucose ... glucose levels through radiowaves from the sensor to ... usage of self-monitoring blood glucose devices can improve ... undergo proper diabetes treatment. Technavio,s analysts ...
    Breaking Medicine Technology:Cipla to acquire 100% of generic businesses in US for $550M 2Cipla to acquire 100% of generic businesses in US for $550M 3Cipla to acquire 100% of generic businesses in US for $550M 4Cipla to acquire 100% of generic businesses in US for $550M 5World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 2World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 3World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 4World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 5World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 6World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 7Global Self-monitoring Blood Glucose Devices Market 2015-2019 2
    (Date:9/4/2015)... ... September 04, 2015 , ... Compliance ... to settlements under the Stark physician self-referral law. “Stark Law DOs and ... from Atlantic Information Services, Inc. (AIS), will detail which deals are attracting the ...
    (Date:9/4/2015)... ... September 04, 2015 , ... Friday night, Chicago lovebirds ... Generation Rescue’s A Night of Hope event supporting families affected by autism, raising nearly ... and Joe Salas, joined together at the Oscar Swan Inn to support the cause. ...
    (Date:9/3/2015)... ... , ... TransPack Toon gives users a set of 90 cartoon transitions for ... in 30 different styles. Presets range from snow, underwater, forest, futuristic, city and many ... features 90 cartoon transitions from 30 unique styles. Editors can choose between line ...
    (Date:9/3/2015)... ... 03, 2015 , ... E-Volve Health, an Elliot Health System ... organization, to provide electronic medical record (EMR) consulting services to Amerinet clients running ... negotiated pricing on E-Volve Health’s Epic EMR consulting, custom training and support services. ...
    (Date:9/3/2015)... Georgia (PRWEB) , ... September 03, 2015 , ... ... spread of disease in Haiti, has partnered with Slingshot® Product Development Group to ... electricity or running water. Michael Wahl with DriButts plans to bring 600 DriButts ...
    Breaking Medicine News(10 mins):Health News:Sept. 17 Webinar to Offer Best Practices for Physician Contracts 2Health News:Jenny McCarthy & Donnie Wahlberg Help Raise Over $200,000 For Generation Rescue’s ‘Night Of Hope’ Chicago Charity Event 2Health News:Pixel Film Studios Releases TransPack Toon, a New FCPX Transition 2Health News:E-Volve Health to Offer EMR Consulting Solutions to Amerinet Members 2Health News:DriButts Diapers Rely on Slingshot Help in Haiti 2Health News:DriButts Diapers Rely on Slingshot Help in Haiti 3
    ... (Nasdaq: ROCM ) today announced operating results for,its ... The Company reported 23% sales growth with record sales ... the fourth quarter of,last year, resulting from increases in ... reported net income of $733,000 or $.06 per,diluted share ...
    ... -- China Nepstar,Chain Drugstore Ltd. (NYSE: NPD ... chain in China based on the number of ... the Company,s initial,public offering ("IPO") have exercised their ... Shares ("ADSs") from the Company at,the IPO price ...
    ... /PRNewswire-FirstCall/ - NovaBay,Pharmaceuticals, Inc. (AMEX & TSX: NBY), ... targeting the,treatment or prevention of a wide range ... the third quarter ended September 30, 2007. ... 2007 was $1.6 million, or,$0.24 per share, as ...
    ... foods lowered odds up to 60%, study found , THURSDAY, ... of fish, omega-3 rich oils, fruits and vegetables may reduce ... of omega-6 rich oils may boost the risk of developing ... the diets of 8,085 people older than 65 who did ...
    ... 2007 The U.S. Pharmacopeia (USP) is pleased ... supplements for public notice and comment. ... monographs appeared in Pharmacopeial Forum (PF) 33(6), the ... Powdered Turmeric, Powdered Turmeric Extract, Curcuminoids, Curcuminoids Capsules, ...
    ... EDMONTON, Alberta, Nov. 15 Medical Services,International Inc. (Pink ... of the excellent independent test results obtained by regulatory,agencies ... interest in the dual,VScan test kit that detects HIV ... are known to be closely associated. It is very ...
    Cached Medicine News:Health News:Rochester Medical Reports Record Fourth Quarter Sales and Record Year 2Health News:Rochester Medical Reports Record Fourth Quarter Sales and Record Year 3Health News:Rochester Medical Reports Record Fourth Quarter Sales and Record Year 4Health News:Rochester Medical Reports Record Fourth Quarter Sales and Record Year 5Health News:Rochester Medical Reports Record Fourth Quarter Sales and Record Year 6Health News:Rochester Medical Reports Record Fourth Quarter Sales and Record Year 7Health News:Rochester Medical Reports Record Fourth Quarter Sales and Record Year 8Health News:Nepstar Chain Drugstore (NPD) Greenshoe Fully Exercised 2Health News:NovaBay announces third quarter 2007 financial results 2Health News:NovaBay announces third quarter 2007 financial results 3Health News:NovaBay announces third quarter 2007 financial results 4Health News:NovaBay announces third quarter 2007 financial results 5Health News:NovaBay announces third quarter 2007 financial results 6Health News:NovaBay announces third quarter 2007 financial results 7Health News:Fish, Fruits, Veggies May Cut Dementia Risk 2Health News:USP announces 11 new proposed monographs for dietary supplements 2Health News:Medical Services Gets Significant Interest in Its Dual VScan Test Kit 2
    Used for traversing and exploring urethral strictures. The malleable tip can be shaped to desired configuration. The proximal end is threaded to attach to standard followers. Supplied sterile in peel...
    ... Used retrograde to ... establish a Peel-Away ureteral ... The temporary protective Peel-Away ... away as the ureteroscope ...
    The removable inflation/injection adapter allows the cystoscope to be removed after the catheter is in place. Supplied sterile in peel-open packages. Intended for one-time use....
    Radiopaque markers are placed at the proximal and distal ends of the balloon. A special pin vise handle is included to stabilize the wire guide during introduction. Supplied sterile in peel-open pack...
    Medicine Products: